Why Is Oil Extraction Capacity a Constraint w/ CMED Takeover
Can somebody here please explain why Aurora is saying that they had oile extraction capacity constraints during this past quarter? They seem to be using this as the reason why their revenues on a per gram basis had gone down for this quarter. I found this rather puzzling since I thought the CanniMed takeover from early last year was going to give them access to more CBD oils than they could conceivably sell at this point in time. Ithought CMED's new production line was supposed to be up and running and able to pump out something like 1.2M bottles of high margin CBD oils by the end of 2018. To tell you the honest truth, this number didn't make much sense to me in the first place as this would have been $1.8B in top line revenue per year, based upon a price point of $150 per bottle. Does anybody have any idea of what happened with this supposed CBD oils that CanniMed was going to tuen out for Aurora???